SCHEMBL16607181

SCHEMBL16607181

CC(=O)Nc1ccc(C(=O)Nc2ncc(Cc3ccc(Cl)cc3)s2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.61
KMT2A Q03164 6/20 0.61
L3MBTL1 Q9Y468 1/20 0.61
ABL1 P00519 1/20 0.60
LMNA P02545 7/20 0.57
FFAR2 O15552 1/20 0.55
KDM4E B2RXH2 3/20 0.55
HTT P42858 3/20 0.55
TP53 P04637 2/20 0.55
MAPT P10636 5/20 0.55
SMN1; SMN2 Q16637 4/20 0.53
OGA O60502 2/20 0.53
GAA P10253 2/20 0.52
ALDH1A1 P00352 1/20 0.52
HPGD P15428 1/20 0.52
SIRT2 Q8IXJ6 1/20 0.52
NPC1 O15118 2/20 0.51
RAB9A P51151 2/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16607122 0.90 KDM4E (0.67) MEN1KMT2AABL1LMNAKDM4E
SCHEMBL16607309 0.89 LMNA (0.61) MEN1KMT2AL3MBTL1ABL1LMNA
SCHEMBL16607214 0.86 LMNA (0.59) MEN1KMT2ALMNAKDM4EHTT
SCHEMBL16607222 0.85 MAPT (0.78) MEN1KMT2AL3MBTL1ABL1LMNA
SCHEMBL21382494 0.80 LMNA (0.59) MEN1KMT2AL3MBTL1ABL1LMNA
SCHEMBL2753858 0.78 ABL1 (0.67) MEN1KMT2AL3MBTL1ABL1LMNA
SCHEMBL16607230 0.78 ABL1 (0.67) MEN1KMT2AL3MBTL1ABL1LMNA
SCHEMBL31237167 0.78 NPC1 (0.63) MEN1KMT2AL3MBTL1ABL1LMNA
SCHEMBL22205273 0.77 LMNA (0.59) MEN1KMT2AL3MBTL1ABL1LMNA
SCHEMBL21382270 0.77 LMNA (0.56) MEN1KMT2AL3MBTL1ABL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10729695-B2 Amino, amido and heterocyclic compounds as modulators of RAGE activity and uses thereof THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2020-08-04 US disclosed
US-10265320-B2 Amino, amido and heterocyclic compounds as modulators of rage activity and uses thereof THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2019-04-23 US disclosed
US-20160263125-A1 AMINO, AMIDO AND HETEROCYCLIC COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF NEW YORK UNIVERSITY 2016-09-15 US disclosed
US-9364472-B2 Amino, Amido and heterocyclic compounds as modulators of RAGE activity and uses thereof NEW YORK UNIVERSITY (US) 2016-06-14 US disclosed
US-9353078-B2 Amino, amido and heterocyclic compounds as modulators of rage activity and uses thereof NEW YORK UNIVERSITY (US) 2016-05-31 US disclosed
US-20160101096-A1 AMINO, AMIDO AND HETEROCYCLIC COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF NEW YORK UNIVERSITY 2016-04-14 US disclosed
WO-2015050984-A1 AMINO, AMIDO, AND HETEROCYCLIC COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF NEW YORK UNIVERSITY (US) 2015-04-09 WO disclosed
US-20150094307-A1 AMINO, AMIDO AND HETEROCYCLIC COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK 2015-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150094307-A1 AMINO, AMIDO AND HETEROCYCLIC COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF AGER, IAPP, GPR119 MEN1 2624/4885KMT2A 4609/4885L3MBTL1 2912/4885
US-10729695-B2 Amino, amido and heterocyclic compounds as modulators of RAGE activity and uses thereof AGER, IAPP, GPR119 MEN1 2624/4885KMT2A 4609/4885L3MBTL1 2912/4885
US-20160263125-A1 AMINO, AMIDO AND HETEROCYCLIC COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF AGER, IAPP, GPR119 MEN1 2624/4885KMT2A 4609/4885L3MBTL1 2912/4885
US-20160101096-A1 AMINO, AMIDO AND HETEROCYCLIC COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF AGER, IAPP, GPR119 MEN1 2624/4885KMT2A 4609/4885L3MBTL1 2912/4885
US-10265320-B2 Amino, amido and heterocyclic compounds as modulators of rage activity and uses thereof AGER, IAPP, GPR119 MEN1 2624/4885KMT2A 4609/4885L3MBTL1 2912/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.